{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:28:20Z","timestamp":1775806100213,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T00:00:00Z","timestamp":1279756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00404-010-1590-2","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T07:34:12Z","timestamp":1279697652000},"page":"59-63","source":"Crossref","is-referenced-by-count":13,"title":["Randomized trial of oral versus sublingual misoprostol 24\u00a0h after mifepristone for medical abortion"],"prefix":"10.1007","volume":"284","author":[{"given":"Krishna","family":"Dahiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonika","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smiti","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,22]]},"reference":[{"issue":"1","key":"1590_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humrep\/deh001","volume":"1","author":"P Saxena","year":"2004","unstructured":"Saxena P, Salhan S, Sarda N (2004) Comparison between the sublingual and oral route of misoprostol for pre-abortion cervical priming in first trimester abortions. Hum Reprod 1(1):77\u201380","journal-title":"Hum Reprod"},{"key":"1590_CR2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-0528.2000.tb13273.x","volume":"107","author":"World Health Organization Task Force on Postovulatory Methods of Fertility Regulation","year":"2000","unstructured":"World Health Organization Task Force on Postovulatory Methods of Fertility Regulation (2000) Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomized trial. Br J Obstet Gynaecol 107:524\u2013530","journal-title":"Br J Obstet Gynaecol"},{"issue":"11","key":"1590_CR3","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/deg475","volume":"18","author":"OS Tang","year":"2003","unstructured":"Tang OS, Chan C, Ng E, Lee S, Ho P (2003) A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9\u00a0weeks gestation. Hum Reprod 18(11):2315\u20132318","journal-title":"Hum Reprod"},{"key":"1590_CR4","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.284.15.1948","volume":"284","author":"EA Schaff","year":"2000","unstructured":"Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS (2000) Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. JAMA 284:1948\u20131953","journal-title":"JAMA"},{"key":"1590_CR5","doi-asserted-by":"crossref","unstructured":"von Hertzen H, Piaggio G, Marions L (2008) Comparison of two doses and two routes of administration of misoprostol after pre-treatment with mifepristone for early pregnancy termination. Reprod Health 5(2). doi: 10.1186\/1742-4755-5-2","DOI":"10.1186\/1742-4755-5-2"},{"key":"1590_CR6","first-page":"54","volume":"58","author":"N Vimala","year":"2004","unstructured":"Vimala N, Mittal S, Kumar S (2004) Sublingual misoprostol before first trimester abortion: a comparative study using two dose regimens. Indian J Med Sci 58:54\u201361","journal-title":"Indian J Med Sci"},{"key":"1590_CR7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","volume":"338","author":"IM Spitz","year":"1998","unstructured":"Spitz IM, Bardin CW, Benton L, Robbins A (1998) Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 338:1241\u20131247","journal-title":"N Engl J Med"},{"key":"1590_CR8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","volume":"17","author":"OS Tang","year":"2002","unstructured":"Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC (2002) Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 17:332\u2013336","journal-title":"Hum Reprod"},{"key":"1590_CR9","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/humrep\/17.7.1738","volume":"17","author":"OS Tang","year":"2002","unstructured":"Tang OS, Xu J, Cheng L, Lee SWH, Ho PC (2002) Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9\u00a0weeks of gestation. Hum Reprod 17:1738\u20131740","journal-title":"Hum Reprod"},{"key":"1590_CR10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-0528.2005.00638.x","volume":"112","author":"H Hamoda","year":"2005","unstructured":"Hamoda H, Ashok PW, Flett GM, Templeton A (2005) A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13\u00a0weeks of gestation. BJOG 112:1102\u20131108","journal-title":"BJOG"},{"issue":"51","key":"1590_CR11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.AOG.0000124271.23499.84","volume":"103","author":"MD Creinin","year":"2004","unstructured":"Creinin MD, Fox MC, Teal S, Chen A, Schaff EA, Meyn LA, MOD Study Trial Group (2004) A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol 103(51):851\u2013859","journal-title":"Obstet Gynecol"},{"issue":"9","key":"1590_CR12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S1470-0328(03)02430-3","volume":"110","author":"H Hertzen Von","year":"2003","unstructured":"Von Hertzen H, Honkanen H, Piaggio G, Bartfai G, Erdenetungalag R, Gemzell-Danielsson K (2003) WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. BJOG 110(9):808\u2013818","journal-title":"BJOG"},{"issue":"2","key":"1590_CR13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1471-0528.2006.01179.x","volume":"114","author":"J Guest","year":"2007","unstructured":"Guest J, Chien PFW, Thomson MAR, Kosseim ML (2007) Randomized controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol. BJOG 114(2):207\u2013215","journal-title":"BJOG"},{"issue":"6","key":"1590_CR14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/AOG.0b013e31818d8eb4","volume":"112","author":"B Winikoff","year":"2008","unstructured":"Winikoff B, Dzuba IG, Creinin MD, Crowden WA, Goldberg AB, Gonzales J (2008) Two distinct routes of administration of misoprostol in mifepristone medical abortion: a randomized controlled trial. Obstet Gynecol 112(6):1303\u20131310","journal-title":"Obstet Gynecol"},{"key":"1590_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(98)00150-4","volume":"59","author":"EA Schaff","year":"1999","unstructured":"Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S (1999) Low-dose mifepristone, 200\u00a0mg, and vaginal misoprostol for induced abortion. Contraception 59:1\u20136","journal-title":"Contraception"},{"issue":"2","key":"1590_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2008.09.001","volume":"7","author":"S Raghavan","year":"2009","unstructured":"Raghavan S, Comendant R, Digol I, Ungureanu S, Friptu V, Bracken H, Winikoff B (2009) Two pill regimens of misoprostol after mifepristone medical abortion through 63\u00a0days\u2019 gestational age: a randomized controlled trial of sublingual and oral misoprostol. Contraception 7(2):84\u201390","journal-title":"Contraception"},{"issue":"3","key":"1590_CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13625180902916020","volume":"14","author":"A Akin","year":"2009","unstructured":"Akin A, Dabash R, Dilbaz B, Aktun H, Dursun P, Kiran S, Aksan G, Dogan B, Winikoff B (2009) Increasing women\u2019s choices in medical abortion: a study of misoprostol 400 \u03bcg swallowed immediately or held sublingually following 200\u00a0mg mifepristone. Eur J Contracept Reprod Health Care 14(3):169\u2013175","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"1590_CR18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.contraception.2009.03.010","volume":"80","author":"M Fjerstad","year":"2009","unstructured":"Fjerstad M, Sivin I, Lichtenberg ES, Trussell J, Cleland K, Cullins V (2009) Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days. Contraception 80(3):282\u2013286","journal-title":"Contraception"},{"issue":"4","key":"1590_CR19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.gyobfe.2005.02.021","volume":"33","author":"P Faucher","year":"2005","unstructured":"Faucher P, Baunot N, Madelenat P (2005) The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients. Gynecol Obstet Fertil 33(4):220\u2013227","journal-title":"Gynecol Obstet Fertil"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1590-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-010-1590-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1590-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T10:21:01Z","timestamp":1559298061000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-010-1590-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,22]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1590"],"URL":"https:\/\/doi.org\/10.1007\/s00404-010-1590-2","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,22]]}}}